Literature DB >> 25624478

Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase.

Christopher N Batuello1, Paula M Hauck2, Jaimie M Gendron1, Jason A Lehman2, Lindsey D Mayo3.   

Abstract

Murine double minute-2 protein (Mdm2) is a multifaceted phosphorylated protein that plays a role in regulating numerous proteins including the tumor suppressor protein p53. Mdm2 binds to and is involved in conjugating either ubiquitin or Nedd8 (Neural precursor cell expressed, developmentally down-regulated 8) to p53. Although regulation of the E3 ubiquitin activity of Mdm2 has been investigated, regulation of the neddylating activity of Mdm2 remains to be defined. Here we show that activated c-Src kinase phosphorylates Y281 and Y302 of Mdm2, resulting in an increase in Mdm2 stability and its association with Ubc12, the E2 enzyme of the neddylating complex. Mdm2-dependent Nedd8 conjugation of p53 results in transcriptionally inactive p53, a process that is reversed with a small molecule inhibitor to either Src or Ubc12. Thus, our studies reveal how Mdm2 may neutralize and elevate p53 in actively proliferating cells and also provides a rationale for using therapies that target the Nedd8 pathway in wild-type p53 tumors.

Entities:  

Keywords:  Mdm2; Nedd8; Src

Mesh:

Substances:

Year:  2015        PMID: 25624478      PMCID: PMC4330765          DOI: 10.1073/pnas.1416656112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.

Authors:  Muyang Li; Christopher L Brooks; Foon Wu-Baer; Delin Chen; Richard Baer; Wei Gu
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

Review 2.  A renaissance for SRC.

Authors:  Timothy J Yeatman
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

3.  Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity.

Authors:  Dimitris P Xirodimas; Mark K Saville; Jean-Christophe Bourdon; Ronald T Hay; David P Lane
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

Review 4.  The interplay between Src family kinases and receptor tyrosine kinases.

Authors:  Paul A Bromann; Hasan Korkaya; Sara A Courtneidge
Journal:  Oncogene       Date:  2004-10-18       Impact factor: 9.867

5.  Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues.

Authors:  T Hojo; Y Akiyama; K Nagasaki; K Maruyama; K Kikuchi; T Ikeda; M Kitajima; K Yamaguchi
Journal:  Cancer Lett       Date:  2001-09-28       Impact factor: 8.679

6.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  c-Abl phosphorylation of Mdm2 facilitates Mdm2-Mdmx complex formation.

Authors:  David L Waning; Jason A Lehman; Christopher N Batuello; Lindsey D Mayo
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

8.  Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.

Authors:  M Hjerrild; D Milne; N Dumaz; T Hay; O G Issinger; D Meek
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

9.  Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.

Authors:  Zehavit Goldberg; Ronit Vogt Sionov; Michael Berger; Yaara Zwang; Ruth Perets; Richard A Van Etten; Moshe Oren; Yoichi Taya; Ygal Haupt
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

Review 10.  Nedd8 on cullin: building an expressway to protein destruction.

Authors:  Zhen-Qiang Pan; Alex Kentsis; Dora C Dias; Kosj Yamoah; Kenneth Wu
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

View more
  14 in total

Review 1.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

2.  SRC Increases MYC mRNA Expression in Estrogen Receptor-Positive Breast Cancer via mRNA Stabilization and Inhibition of p53 Function.

Authors:  Christopher Abdullah; Hasan Korkaya; Shinji Iizuka; Sara A Courtneidge
Journal:  Mol Cell Biol       Date:  2018-02-27       Impact factor: 4.272

Review 3.  Protein neddylation and its alterations in human cancers for targeted therapy.

Authors:  Lisha Zhou; Wenjuan Zhang; Yi Sun; Lijun Jia
Journal:  Cell Signal       Date:  2018-01-10       Impact factor: 4.315

4.  Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK.

Authors:  Eric R Wolf; Ciarán P McAtarsney; Kristin E Bredhold; Amber M Kline; Lindsey D Mayo
Journal:  Sci Signal       Date:  2018-04-03       Impact factor: 8.192

Review 5.  Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.

Authors:  David J Olivos; Lindsey D Mayo
Journal:  Int J Mol Sci       Date:  2016-11-26       Impact factor: 5.923

6.  The fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2).

Authors:  Paula M Hauck; Eric R Wolf; David J Olivos; Ciaran P McAtarsney; Lindsey D Mayo
Journal:  Oncotarget       Date:  2017-11-06

7.  Src SUMOylation Inhibits Tumor Growth Via Decreasing FAK Y925 Phosphorylation.

Authors:  Jing Wang; Rong Deng; Nan Cui; Hailong Zhang; Tianqi Liu; Jinzhuo Dou; Xian Zhao; Ran Chen; Yanli Wang; Jianxiu Yu; Jian Huang
Journal:  Neoplasia       Date:  2017-10-22       Impact factor: 5.715

8.  Mdm2-mediated neddylation of pVHL blocks the induction of antiangiogenic factors.

Authors:  Eric R Wolf; Alexander R Mabry; Blossom Damania; Lindsey D Mayo
Journal:  Oncogene       Date:  2020-06-17       Impact factor: 9.867

Review 9.  P53, GHRH, inflammation and cancer.

Authors:  Nektarios Barabutis; Andrew V Schally; Agnieszka Siejka
Journal:  EBioMedicine       Date:  2018-10-19       Impact factor: 8.143

Review 10.  Neddylation: A Versatile Pathway Takes on Chronic Liver Diseases.

Authors:  Jiping Yao; Xue Liang; Yanning Liu; Min Zheng
Journal:  Front Med (Lausanne)       Date:  2020-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.